Home NDC 68071-5271 Febuxostat
Product NDC 68071-5271
11-digit product format 680715271
Labeler code 68071
Product ID 68071-5271_1d7908f6-b143-36ea-e063-6394a90a4cbb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Febuxostat
Dosage form TABLET, FILM COATED
Route ORAL
Labeler NuCare Pharmaceuticals,Inc.
Application ANDA210461
Marketing category ANDA
Marketing start 2019-12-30
Substance FEBUXOSTAT
Active strength 40 mg/1
Pharmacologic classes Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210461-001 FEBUXOSTAT FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 A210461-002 FEBUXOSTAT FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 76 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL BX 2019-12-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL BX 2019-12-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A210461-001 FEBUXOSTAT 40MG TABLET / ORAL AB 2019-12-30 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A210461-002 FEBUXOSTAT 80MG TABLET / ORAL AB 2019-12-30 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 76 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Febuxostat
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FEBUXOSTAT 40 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 101V0R1N2E Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 834235 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68071-5271-3 Febuxostat 30 in 1 BOTTLE TABLET, FILM COATED 30 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68071-5271 FEBUXOSTAT TABLET, FILM COATED [NUCARE PHARMACEUTICALS,INC.] 3 Current NDC, Legacy NDC, 1 package rows 20240719_a745be75-4fa5-cbf9-e053-2995a90a3a81.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Febuxostat FEBUXOSTAT Novadoz Pharmaceuticals LLC d1969ea8-5178-42ee-97fc-feee8595e677 2026-02-20 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 210461 application number: ANDA210461 Febuxostat FEBUXOSTAT Major Pharmaceuticals 164feabd-f722-445b-b81a-d975b3db5f53 2025-11-14 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 210461 application number: ANDA210461 Febuxostat FEBUXOSTAT NuCare Pharmaceuticals,Inc. a745be75-4fa5-cbf9-e053-2995a90a3a81 2024-07-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 210461 application number: ANDA210461 ndc (product): 68071-5271 Febuxostat FEBUXOSTAT MAJOR PHARMACEUTICALS 13a80059-46f7-4453-ab37-72744657a08a 2024-06-04 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 210461 application number: ANDA210461 Febuxostat FEBUXOSTAT Aphena Pharma Solutions - Tennessee, LLC bf4d29c8-4731-42bc-887a-d8302add9ca9 2020-04-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 210461 application number: ANDA210461
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 68071-5271-3 68071527103 30 TABLET, FILM COATED in 1 BOTTLE (68071-5271-3) 2020-06-04 0000-00-00 No No Current